ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025
Case series of Oropouche fever among travellers returning from Cuba to Spain, 2024.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Are mosquito species present in Spain competent for Oropouche virus?Parasites & vectors · 2026Article
- Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.EClinicalMedicine · 2026Review
- Comprehensive analysis of epidemiological and clinical features of Oropouche virus infection (1975 to 2025): a systematic review.New microbes and new infections · 2026Review
- Clinical and Epidemiological Characteristics of an Oropouche Virus Outbreak in Loreto, Peru (October 2024-March 2025).Pathogens (Basel, Switzerland) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oropouche fever is a vector-borne disease endemic in Central and South America. Infection with Oropouche virus (OROV) was confirmed in June and July 2024 in 13 patients travelling from Cuba to Spain. These patients presented fever, headache, myalgia and arthralgia, and three patients exhibited a biphasic course, with two developing transient neurological symptoms. Oropouche virus infection was diagnosed using reverse transcription quantitative PCR (RT-qPCR) and neutralisation tests. Viral RNA was detected in specimens from serum, urine, plasma and whole blood; from four urine samples up to 24 days post-symptom onset. Phylogenetic analysis of one OROV strain (OROV SP2024) isolated from one patient, demonstrated it clustered closely with reassortant strains circulating in Brazil and imported cases in Italy. These findings underscore the importance of including OROV in the differential diagnosis of febrile illnesses in returning travellers and demonstrate the diagnostic value of analysing multiple sample types. Enhanced clinical awareness and diagnostic capacity are essential to improve detection and surveillance of OROV among international travellers from affected regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.